Literature DB >> 28511928

Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.

Eva Zupančič1, Caterina Curato2, Maria Paisana3, Catarina Rodrigues3, Ziv Porat4, Ana S Viana5, Carlos A M Afonso3, João Pinto3, Rogério Gaspar3, João N Moreira6, Ronit Satchi-Fainaro7, Steffen Jung2, Helena F Florindo8.   

Abstract

Vaccination is a promising strategy to trigger and boost immune responses against cancer or infectious disease. We have designed, synthesized and characterized aliphatic-polyester (poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP) to investigate how the nature of protein association (adsorbed versus entrapped) and polymer/surfactant concentrations impact on the generation and modulation of antigen-specific immune responses. The ability of the NP formulations to target dendritic cells (DC), be internalized and activate the T cells was characterized and optimized in vitro and in vivo using markers of DC activation and co-stimulatory molecules. Ovalbumin (OVA) was used as a model antigen in combination with the engraftment of CD4+ and CD8+ T cells, carrying a transgenic OVA-responding T cell receptor (TCR), to trace and characterize the activation of antigen-specific CD4+ and CD8+ lymph node T cells upon NP vaccination. Accordingly, the phenotype and frequency of immune cell stimulation induced by the NP loaded with OVA, isolated or in combination with synthetic unmethylated cytosine-phosphate-guanine (CpG) oligodeoxynucleotide (ODN) motifs, were characterized. DC-NP interactions increased with incubation time, presenting internalization values between 50 and 60% and 30-40%, in vitro and in vivo, respectively. Interestingly, animal immunization with antigen-adsorbed NP up-regulated major histocompatibility complex (MHC) class II (MHCII), while NP entrapping the antigen up-regulated MHCI, suggesting a more efficient cross-presentation. On the other hand, rather surprisingly, the surfactant used in the NP formulation had a major impact on the activation of antigen presenting cells (APC). In fact, DC collected from lymph nodes of animals immunized with NP prepared using poly(vinil alcohol) (PVA), as a surfactant, expressed significantly higher levels of CD86, MHCI and MHCII. In addition, those NP prepared with PVA and co-entrapping OVA and the toll-like receptor (TLR) ligand CpG, induced the most profound antigen-specific T cell response, by both CD4+ and CD8+ T cells, in vivo. Overall, our data reveal the impact of NP composition and surface properties on the type and extension of induced immune responses. Deeper understanding on the NP-immune cell crosstalk can guide the rational development of nano-immunotherapeutic systems with improved and specific therapeutic efficacy and avoiding off-target effects.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-lactalbumin; Dendritic cells; Ovalbumin; PLGA-peg; Polymeric nanoparticles; Vaccine delivery

Mesh:

Substances:

Year:  2017        PMID: 28511928     DOI: 10.1016/j.jconrel.2017.05.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   11.467


  17 in total

1.  BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications.

Authors:  Jooeun Bae; Neha Parayath; Wenxue Ma; Mansoor Amiji; Nikhil Munshi; Kenneth C Anderson
Journal:  Leukemia       Date:  2019-08-19       Impact factor: 11.528

2.  α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.

Authors:  Vanessa Sainz; Liane I F Moura; Carina Peres; Ana I Matos; Ana S Viana; Angela M Wagner; Julia E Vela Ramirez; Teresa S Barata; Manuela Gaspar; Steve Brocchini; Mire Zloh; Nicholas A Peppas; Ronit Satchi-Fainaro; Helena F Florindo
Journal:  Acta Biomater       Date:  2018-06-22       Impact factor: 8.947

3.  The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.

Authors:  Yue Zhang; Pengfei Gu; Adelijiang Wusiman; Shuwen Xu; Haiyu Ni; Tianxin Qiu; Zhenguang Liu; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Int J Nanomedicine       Date:  2020-08-05

4.  Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Haemonchus contortus HCA59 Antigen in Model Mice.

Authors:  Qiangqiang Wang; Xiaoke Sun; Xin Huang; Jianmei Huang; Muhammad Waqqas Hasan; RuoFeng Yan; Lixin Xu; Xiaokai Song; Xiangrui Li
Journal:  Int J Nanomedicine       Date:  2021-05-04

5.  Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.

Authors:  Emilie Bayon; Jessica Morlieras; Nathalie Dereuddre-Bosquet; Alexis Gonon; Leslie Gosse; Thomas Courant; Roger Le Grand; Patrice N Marche; Fabrice P Navarro
Journal:  NPJ Vaccines       Date:  2018-10-01       Impact factor: 7.344

6.  DC Respond to Cognate T Cell Interaction in the Antigen-Challenged Lymph Node.

Authors:  Caterina Curato; Biana Bernshtein; Eva Zupancič; Almut Dufner; Diego Jaitin; Amir Giladi; Eyal David; Louise Chappell-Maor; Dena Leshkowitz; Klaus-Peter Knobeloch; Ido Amit; Helena F Florindo; Steffen Jung
Journal:  Front Immunol       Date:  2019-04-25       Impact factor: 7.561

7.  Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen.

Authors:  Tamara G Dacoba; Robert W Omange; Hongzhao Li; José Crecente-Campo; Ma Luo; Maria Jose Alonso
Journal:  ACS Nano       Date:  2019-04-23       Impact factor: 15.881

8.  Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.

Authors:  Maritsa Margaroni; Maria Agallou; Evita Athanasiou; Olga Kammona; Costas Kiparissides; Catherine Gaitanaki; Evdokia Karagouni
Journal:  Int J Nanomedicine       Date:  2017-08-23

Review 9.  Immune-mediated approaches against COVID-19.

Authors:  Helena F Florindo; Ron Kleiner; Daniella Vaskovich-Koubi; Rita C Acúrcio; Barbara Carreira; Eilam Yeini; Galia Tiram; Yulia Liubomirski; Ronit Satchi-Fainaro
Journal:  Nat Nanotechnol       Date:  2020-07-13       Impact factor: 40.523

Review 10.  Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.

Authors:  Shan Gao; Dongjuan Yang; Yan Fang; Xiaojie Lin; Xuechao Jin; Qi Wang; Xiyan Wang; Liyuan Ke; Kai Shi
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.